» Articles » PMID: 28795196

Melatonin and Mitochondrial Function During Ischemia/reperfusion Injury

Overview
Publisher Springer
Specialty Biology
Date 2017 Aug 11
PMID 28795196
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemia/reperfusion (IR) injury occurs in many organs and tissues, and contributes to morbidity and mortality worldwide. Melatonin, an endogenously produced indolamine, provides a strong defense against IR injury. Mitochondrion, an organelle for ATP production and a decider for cell fate, has been validated to be a crucial target for melatonin to exert its protection against IR injury. In this review, we first clarify the mechanisms underlying mitochondrial dysfunction during IR and melatonin's protection of mitochondria under this condition. Thereafter, special focus is placed on the protective actions of melatonin against IR injury in brain, heart, liver, and others. Finally, we explore several potential future directions of research in this area. Collectively, the information compiled here will serve as a comprehensive reference for the actions of melatonin in IR injury identified to date and will hopefully aid in the design of future research and increase the potential of melatonin as a therapeutic agent.

Citing Articles

Exploring the Therapeutic Mechanism of Xinbao Pill in Brain Injury After Cardiopulmonary Resuscitation Based on Network Pharmacology, Metabolomics, and Experimental Verification.

Li D, Wu Q, Li Z, Chen B, Sun X, Wu Q CNS Neurosci Ther. 2025; 31(3):e70297.

PMID: 40035287 PMC: 11877134. DOI: 10.1111/cns.70297.


Expression of LncRNAs in anterior capsule of lens in patients with pathologic myopia complicated with cataract.

Hu Y, Fan Y, Li N, Xu C, Wang J Int Ophthalmol. 2024; 45(1):10.

PMID: 39680214 DOI: 10.1007/s10792-024-03366-5.


Melatonin attenuates liver ischemia-reperfusion injury via inhibiting the PGAM5-mPTP pathway.

Shi X, Zhang J, Gao J, Guo D, Zhang S, Chen X PLoS One. 2024; 19(10):e0312853.

PMID: 39471139 PMC: 11521291. DOI: 10.1371/journal.pone.0312853.


The Effect of Hypoxia on Irisin Expression in HL-1 Cardiomyocytes.

Grzeszczuk M, Mrozowska M, Kmiecik A, Rusak A, Jablonska K, Ciesielska U In Vivo. 2024; 38(5):2126-2133.

PMID: 39187335 PMC: 11363745. DOI: 10.21873/invivo.13675.


Insight into the cardioprotective effects of melatonin: shining a spotlight on intercellular Sirt signaling communication.

Yaghoobi A, Rezaee M, Hedayati N, Keshavarzmotamed A, Khalilzad M, Russel R Mol Cell Biochem. 2024; 480(2):799-823.

PMID: 38980593 DOI: 10.1007/s11010-024-05002-3.


References
1.
Gao L, Zhao Y, Liang Y, Lin X, Tan Y, Wu D . The impaired myocardial ischemic tolerance in adult offspring of diabetic pregnancy is restored by maternal melatonin treatment. J Pineal Res. 2016; 61(3):340-52. DOI: 10.1111/jpi.12351. View

2.
Okur M, Arslan S, Aydogdu B, Zeytun H, Basuguy E, Arslan M . Protective Effect of Cordycepin on Experimental Testicular Ischemia/Reperfusion Injury in Rats. J Invest Surg. 2017; 31(1):1-8. DOI: 10.1080/08941939.2016.1246629. View

3.
Yu J, Wei J, Ji L, Hong X . Exploration on mechanism of a new type of melatonin receptor agonist Neu-p11 in hypoxia-reoxygenation injury of myocardial cells. Cell Biochem Biophys. 2014; 70(2):999-1003. DOI: 10.1007/s12013-014-0009-2. View

4.
Manchester L, Coto-Montes A, Boga J, Andersen L, Zhou Z, Galano A . Melatonin: an ancient molecule that makes oxygen metabolically tolerable. J Pineal Res. 2015; 59(4):403-19. DOI: 10.1111/jpi.12267. View

5.
Yip H, Chang Y, Wallace C, Chang L, Tsai T, Chen Y . Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia-reperfusion injury. J Pineal Res. 2012; 54(2):207-21. DOI: 10.1111/jpi.12020. View